Quantitative motor readouts as provided by QuantiMedis have been used in the following publications:

• 1: Tabrizi SJ, Reilmann R, et al. TRACK-HD investigators. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 2012, 11:42-53. PubMed PMID: 22137354.
• 2: Reilmann R, et al. Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function? J Neurol. 2012 Aug 8. PubMed PMID: 22872165.
• 3: Reilmann R, et al. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures. Mov Disord. 2011, 26:2267-73. PubMed PMID: 21661053.
• 4: Bechtel N, ..., Reilmann R. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010, 75:2150-60. PubMed PMID: 21068430.
• 5: Reilmann R, et al. Grasping premanifest Huntington's disease - shaping new endpoints for new trials. Mov Disord. 2010, 25:2858-62. PubMed PMID: 20818671.
• 6: Reilmann R, et al. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Mov Disord. 2010, 25:2195-202. PubMed PMID: 20645403.
• 7: Tabrizi SJ, ..., Reilmann R, et al. TRACK-HD investigators. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009, 8:791 -801. PubMed PMID: 19646924.
• 8: Reilmann R, et al. Huntington's disease: objective assessment of posture--a link between motor and functional deficits. Mov Disord. 2012, 27:555-9. PubMed PMID: 22241673.
• 9: Delmaire C, ..., Reilmann, et al. The structural correlates of functional deficits in early Huntington's disease. Hum Brain Mapp. 2012 Mar 22. doi: 10.1002/hbm.22055. PubMed PMID: 22438242.
• 10: van den Bogaard SJ, ..., Reilmann R, et al. Magnetization Transfer Imaging in Premanifest and Manifest Huntington Disease: A 2-Year Follow-Up. AJNR Am J Neuroradiol. 2012 Aug 23. PubMed PMID: 22918430.
• 11: van den Bogaard SJ, ..., Reilmann R, et al. Magnetization transfer imaging in premanifest and manifest Huntington disease. AJNR Am J Neuroradiol. 2012, 33:884-9. PubMed PMID: 22241387.
• 12: Scahill RI, ..., Reilmann R, et al. TRACK-HD investigators. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Hum Brain Mapp. 2011 Nov 18. doi: 10.1002/hbm.21449. PubMed PMID: 22102212.
• 13: Tabrizi SJ, ..., Reilmann R, et al. TRACK-HD Investigators. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011 Jan; 10(1):31-42. PubMed PMID: 21130037.
• 14: Sturrock A, ..., Reilmann R, et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 2010, 75:1702-10. PubMed PMID: 21060093.
• 15: Muratori LM., Reilmann R, et al. Coordination of fingertip forces during precision grasping in multiple system atrophy. Neuropsychologia. 2003, 41:1498-508. PubMed PMID: 12849768.
• 16: Reilmann R, et al. Initiation and development of fingertip forces during whole-hand grasping. Exp Brain Res. 2001, 140:443-52. PubMed PMID: 11685397.
• 17: Reilmann R, et al. Objective assessment of progression in Huntington's disease: a 3-year follow-up study. Neurology. 2001, 57:920-4. PubMed PMID: 11552034.